drugset
drugset / Trial / NCT03877471

Mesenchymal Stem Cells (MSCs) - Like Cell Transplantation in Women With Primary Ovarian Insufficiency

NCT03877471 ↗

Phase 1 Unknown 28 enrolled Chinese Academy of Sciences National Natural Science Foundation of China · collabThe First Affiliated Hospital of Zhengzhou University · collab
Non-randomizedSequentialOpen-labelTreatment

Summary

There is a high incidence of women suffering from Primary Ovarian Insufficiency (POI). So far, there was no treatment sufficient enough to cure POI. Cell therapy is a rapidly developing field and have shown immense promise in the treatment of ovarian dysfunction. In this study, the investigator will evaluate the safety of MSC-like cell therapy in women suffering from POI.

Timeline

Start
2019-04-03
Primary completion
2020-07-01
Completion
2021-12-31

Drugs

EvaluationDrugModalityDoseRoute
Subject MSC-like cells Unknown 2e+06 cells Other
Subject MSC-like cells Unknown 5e+06 cells Other
Subject MSC-like cells Unknown 1e+07 cells Other

Indications

primary ovarian failure